Subscribe

International Society for Stem Cell Research (ISSCR)

Inhibitory Interneuron Cell Therapy Reduces Seizures in First 2 Patients With MTLE

Inhibitory Interneuron Cell Therapy Reduces Seizures in First 2 Patients With MTLE

ByVictoria Johnson

June 20th 2023

Data from a phase 1/2 clinical trial of NRTX-1001 were presented at the ISSCR 2023 Annual Meeting.

Point-of-Care CAR T-Cell Therapy Yields 100% ORR in R/R CLL With or Without Richter’s Transformation

Point-of-Care CAR T-Cell Therapy Yields 100% ORR in R/R CLL With or Without Richter’s Transformation

ByVictoria Johnson

June 15th 2023

The phase 1/2 Euplagia-1 trial is currently ongoing in Europe.

Trending on CGTlive®

Sanofi’s Neovascular Age-Related Macular Degeneration Gene Therapy SAR402663 Garners FDA Fast Track Designation

Around the Helix: Cell and Gene Therapy Company Updates – September 17, 2025

© 2025 MJH Life Sciences^®

All rights reserved.